Dear Fetal Heart Society Membership,
With the support of the FHS, we are reaching out to request your participation in our survey examining the variation in current clinical surveillance and management approaches for anti-SSA/Ro antibody positive pregnancies. As care of the pregnant mother with anti-SSA/Ro antibodies crosses multiple disciplines, this survey is targeting pediatric/fetal cardiology, perinatology, obstetric, and family practice providers.
This survey should take approximately 10 minutes and your response is anonymous. Your participation is extremely valuable to us. For those respondents currently participating in the Surveillance and Treatment tO Prevent Fetal Atrioventricular Block Likely to Occur Quickly (STOP BLOQ) study, we aim to collect your baseline practice approach prior to the initiation of this study.Please follow this link to the RedCap survey:
Thank you for your participation,
Lisa Howley, MD (The Children’s Heart Clinic/Children’s Minnesota)
Stacy A. S. Killen, MD, MSCI (Vanderbilt University Medical Center/Monroe Carell Jr. Children’s Hospital at Vanderbilt)
Erin A. Paul, MD (Icahn School of Medicine at Mount Sinai/Mount Sinai Kravis Children’s Hospital)
Anita Krishnan, MD (Children’s National Medical Center)
Melanie Gropler, MD (Rainbow Babies and Children’s Hospital)
Bailey Drewes, MS (Children’s Colorado)
Bettina Cuneo, MD (Children’s Colorado)
Jill Buyon, MD (New York University)
